Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01507948 · ClinicalTrials.gov registry record · NA
Brain Imaging of Psychotherapy for Posttraumatic Stress Disorder (PTSD)
A NA study of Posttraumatic Stress Disorder (PTSD), sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 94
- Enrollment target
- 2
- Study locations
NCT01507948: Completed NA study of Posttraumatic Stress Disorder (PTSD), sponsored by Stanford University.
NCT01507948 is a NA study of Posttraumatic Stress Disorder (PTSD) that has completed, run by Stanford University. The registered enrollment target is 94 participants, below the 109-participant average among 31 other Posttraumatic Stress Disorder (PTSD) trials with a reported enrollment target (14% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01507948, a NA study of Posttraumatic Stress Disorder (PTSD), has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
- 2
- Study locations
Study Summary
The investigators are seeking people who have been exposed to a traumatic event in the past and have symptoms of posttraumatic stress disorder (PTSD) currently. A person with PTSD may feel significant distress when reminded of a traumatic event or feel depressed, anxious or jumpy. As a part of this study, participants will receive brain MRIs and office assessments before and after psychotherapy. The investigators provide the gold-standard psychotherapy for PTSD, "Prolonged Exposure", free of charge; additionally participants are compensated for their time during assessment procedures. This study is exploring the brain circuitry involved in improvement in response to psychotherapy.
Primary Outcome
The CAPS is a 30-item structured interview that corresponds to the DSM-IV criteria for PTSD. In addition to assessing the 17 PTSD symptoms, questions target the impact of symptoms on social and occupational functioning, improvement in symptoms since a previous CAPS administration, overall response validity, overall PTSD severity, and frequency and intensity of five associated symptoms (guilt over acts, survivor guilt, gaps in awareness, depersonalization, and derealization). For each item, stand
Conditions Studied
Interventions
- BEHAVIORAL Prolonged exposure
Study Locations (2)
California
- VA Palo Alto Healthcare System - Palo Alto
- Stanford University, Department of Psychiatry - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2010-09 |
| Est. Completion | 2016-01 |
| Phase | NA |
What the finished NCT01507948 record still lists
NCT01507948 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 109-participant average among 31 other Posttraumatic Stress Disorder (PTSD) trials with a reported enrollment target (14% lower).
The record links to 1 condition, with Posttraumatic Stress Disorder (PTSD) appearing as the primary indexed condition, and to 1 intervention - of which Prolonged exposure is the first listed.
NCT01507948 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01507948 about?
NCT01507948 is a clinical study titled "Brain Imaging of Psychotherapy for Posttraumatic Stress Disorder (PTSD)". The investigators are seeking people who have been exposed to a traumatic event in the past and have symptoms of posttraumatic stress disorder (PTSD) currently. A person with PTSD may feel significant distress when reminded of a traumatic event or feel depressed, anxious or jumpy. As a part of this...
What is the current status of trial NCT01507948?
This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2010-09. Estimated completion is 2016-01.
What conditions does trial NCT01507948 study?
This clinical trial studies the following conditions: Posttraumatic Stress Disorder (PTSD).
What interventions are being tested in trial NCT01507948?
The interventions under investigation include: Prolonged exposure (BEHAVIORAL).
Who is sponsoring clinical trial NCT01507948?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01507948 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Posttraumatic Stress Disorder (PTSD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01507948's enrollment target sits among peer trials
94 16th of 31 higher than 16 of 31 other Posttraumatic Stress Disorder (PTSD) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Posttraumatic Stress Disorder (PTSD) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment for PTSD and Tinnitus
RECRUITING · NA
-
A Neurosensory Account of Anxiety and Stress (Study 2)
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Mindful Self-Compassion to Address PTSD and Substance Use in Unhoused Women
RECRUITING · NA
-
Integrated Treatment for Opioid Use Disorder and PTSD
RECRUITING · NA
-
A Neurosensory Account of Anxiety and Stress (Study 1)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia